These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34896929)

  • 21. Oscillatory activity and cortical coherence of the nucleus basalis of Meynert in Parkinson's disease dementia.
    Nazmuddin M; Oterdoom DLM; van Dijk JMC; van Zijl JC; Kampman AK; Drost G; van Laar T; Beudel M
    Parkinsonism Relat Disord; 2018 Jul; 52():102-106. PubMed ID: 29665982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep brain stimulation and cognitive decline in Parkinson's disease: The predictive value of electroencephalography.
    Markser A; Maier F; Lewis CJ; Dembek TA; Pedrosa D; Eggers C; Timmermann L; Kalbe E; Fink GR; Burghaus L
    J Neurol; 2015 Oct; 262(10):2275-84. PubMed ID: 26159102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deep brain stimulation for dementias.
    Xu DS; Ponce FA
    Neurosurg Focus; 2018 Aug; 45(2):E8. PubMed ID: 30064323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of white matter lesions on the cognitive outcome of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Blume J; Lange M; Rothenfusser E; Doenitz C; Bogdahn U; Brawanski A; Schlaier J
    Clin Neurol Neurosurg; 2017 Aug; 159():87-92. PubMed ID: 28582689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulate or degenerate: deep brain stimulation of the nucleus basalis Meynert in Alzheimer dementia.
    Hardenacke K; Kuhn J; Lenartz D; Maarouf M; Mai JK; Bartsch C; Freund HJ; Sturm V
    World Neurosurg; 2013; 80(3-4):S27.e35-43. PubMed ID: 23246738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deep brain stimulation of the nucleus basalis of Meynert modulates hippocampal-frontoparietal networks in patients with advanced Alzheimer's disease.
    Jiang Y; Yuan TS; Chen YC; Guo P; Lian TH; Liu YY; Liu W; Bai YT; Zhang Q; Zhang W; Zhang JG
    Transl Neurodegener; 2022 Dec; 11(1):51. PubMed ID: 36471370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson's Disease Dementia: A 36 Months Follow Up Study.
    Cappon D; Gratwicke J; Zrinzo L; Akram H; Hyam J; Hariz M; Limousin P; Foltynie T; Jahanshahi M
    Mov Disord Clin Pract; 2022 Aug; 9(6):765-774. PubMed ID: 35937485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive Improvements After Intermittent Deep Brain Stimulation of the Nucleus Basalis of Meynert in a Transgenic Rat Model for Alzheimer's Disease: A Preliminary Approach.
    Koulousakis P; van den Hove D; Visser-Vandewalle V; Sesia T
    J Alzheimers Dis; 2020; 73(2):461-466. PubMed ID: 31868670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations.
    Mangone G; Bekadar S; Cormier-Dequaire F; Tahiri K; Welaratne A; Czernecki V; Pineau F; Karachi C; Castrioto A; Durif F; Tranchant C; Devos D; Thobois S; Meissner WG; Navarro MS; Cornu P; Lesage S; Brice A; Welter ML; Corvol JC;
    Parkinsonism Relat Disord; 2020 Jul; 76():56-62. PubMed ID: 32866938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction in Volume of Nucleus Basalis of Meynert Is Specific to Parkinson's Disease and Progressive Supranuclear Palsy but Not to Multiple System Atrophy.
    Rogozinski S; Klietz M; Respondek G; Oertel WH; Grothe MJ; Pereira JB; Höglinger GU
    Front Aging Neurosci; 2022; 14():851788. PubMed ID: 35431891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversing cognitive-motor impairments in Parkinson's disease patients using a computational modelling approach to deep brain stimulation programming.
    Frankemolle AM; Wu J; Noecker AM; Voelcker-Rehage C; Ho JC; Vitek JL; McIntyre CC; Alberts JL
    Brain; 2010 Mar; 133(Pt 3):746-61. PubMed ID: 20061324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy.
    Rothlind JC; York MK; Carlson K; Luo P; Marks WJ; Weaver FM; Stern M; Follett K; Reda D;
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):622-9. PubMed ID: 25185211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep brain stimulation of the nucleus basalis of Meynert attenuates early EEG components associated with defective sensory gating in patients with Alzheimer disease - a two-case study.
    Dürschmid S; Reichert C; Kuhn J; Freund HJ; Hinrichs H; Heinze HJ
    Eur J Neurosci; 2020 Mar; 51(5):1201-1209. PubMed ID: 29055119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deep Brain Stimulation in Alzheimer's Disease: Targeting the Nucleus Basalis of Meynert.
    Chen YS; Shu K; Kang HC
    J Alzheimers Dis; 2021; 80(1):53-70. PubMed ID: 33492288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson's disease.
    Kim HJ; Jeon BS; Paek SH; Lee KM; Kim JY; Lee JY; Kim HJ; Yun JY; Kim YE; Yang HJ; Ehm G
    J Neurol; 2014 Jun; 261(6):1090-6. PubMed ID: 24687897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deep brain stimulation for the treatment of Alzheimer disease and dementias.
    Laxton AW; Lozano AM
    World Neurosurg; 2013; 80(3-4):S28.e1-8. PubMed ID: 22722036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.